Q1 2025 Holdings
Filed 2025-05-15 | 66 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ELI Lilly & Co(LLY) | COM | 532457108 | $226.1M | 273,778 | 16.4% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $69.5M | 331,741 | 5.0% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $66.1M | 491,334 | 4.8% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $65.6M | 97,498 | 4.8% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $64.9M | 556,545 | 4.7% |
| Select Sector Spdr TR(XLV)Call | SBI HEALTHCARE | 81369Y209 | $62.7M | 429,700 | 4.6% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $61.6M | 126,989 | 4.5% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $46.1M | 93,073 | 3.3% |
| Penumbra Inc(PEN) | COM | 70975L107 | $44.5M | 166,261 | 3.2% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $42.5M | 595,206 | 3.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $40.8M | 68,999 | 3.0% |
| Elevance Health Inc(ELV) | COM | 036752103 | $38.4M | 88,222 | 2.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $31.4M | 908,135 | 2.3% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $29.2M | 155,520 | 2.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $29.1M | 186,916 | 2.1% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $27.5M | 379,954 | 2.0% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $27.3M | $23,000,000 | 2.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $26.8M | 77,464 | 1.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $23.5M | 87,145 | 1.7% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $23.1M | 70,088 | 1.7% |
| Danaher Corporation(DHR) | COM | 235851102 | $23.1M | 112,475 | 1.7% |
| CVS Health Corp(CVS) | COM | 126650100 | $21.2M | 312,305 | 1.5% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $21.0M | 91,571 | 1.5% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $19.7M | 111,854 | 1.4% |
| Waters Corp(WAT) | COM | 941848103 | $19.1M | 51,858 | 1.4% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $18.8M | 35,904 | 1.4% |
| Outset MED Inc(OM) | COM NEW | 690145206 | $18.6M | 1,685,727 | 1.4% |
| Humana Inc(HUM) | COM | 444859102 | $16.7M | 63,238 | 1.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $11.4M | 926,424 | 0.8% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $11.3M | 860,821 | 0.8% |
| Indivior PLC(INDV) | ORD | G4766E116 | $11.1M | 1,159,833 | 0.8% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $11.0M | 150,200 | 0.8% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $10.9M | 21,897 | 0.8% |
| Spdr SER TR(XRT)Call | S&P RETAIL ETF | 78464A714 | $10.9M | 157,200 | 0.8% |
| Sarepta Therapeutics Inc | NOTE 1.250% 9/1 | 803607AD2 | $9.3M | $10,000,000 | 0.7% |
| Centene Corp del(CNC) | COM | 15135B101 | $8.2M | 135,398 | 0.6% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $8.2M | 570,546 | 0.6% |
| Icon PLC(ICLR) | SHS | G4705A100 | $7.2M | 41,038 | 0.5% |
| Uniqure NV(QURE) | SHS | N90064101 | $6.4M | 599,967 | 0.5% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $6.1M | 439,283 | 0.4% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $6.1M | 160,866 | 0.4% |
| Neogenomics Inc(NEO) | COM NEW | 64049M209 | $5.6M | 585,381 | 0.4% |
| Erasca Inc(ERAS) | COM | 29479A108 | $4.8M | 3,489,559 | 0.3% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $4.7M | 197,307 | 0.3% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $4.1M | 46,453 | 0.3% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $3.6M | 3,301,942 | 0.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $3.2M | 50,809 | 0.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.1M | 92,236 | 0.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $3.0M | 834,135 | 0.2% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $2.6M | 2,341,107 | 0.2% |